Skip to main content
US EQUITIES AFTER-HOURS CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
BB

BBCETF / FundVirtus Biotech Clinical Trials Etf

$39.77 last close 2026-11-18
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment BBC's does — no target price to set, unlike a price alert.

Sharia status
NOT COMPLIANT
Screened by look-through to its filed holdings — 53% of portfolio weight covered
Fund look-through

Virtus Biotech Clinical Trials Etf ETF · ETFis Series Trust I

132 holdings · as of 2026-07-31 (3.6 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.

This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 103% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.

NON-COMPLIANT At least 49.16% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 49% turns out to be. Matching more holdings can only raise this share, never lower it.

132 holdings, 76 matched (53% of weight). Portfolio as of 2026-07-31, filed 2026-09-29. Source: SEC Form N-PORT.

25.00% of this portfolio’s income is non-permissible — weighted across holdings, computed over 23% of portfolio weight (33 of 132 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.

Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.

All holdings (132)
HoldingStatusWeightEvery methodology, and the debt ratio behind it
DREYFUS GOVERNMENT CASH MANAGE UNSCREENED 3.48% no in-house ratios for this holding
FIRST TRACKS BIOTHERAPEUTICS INC UNSCREENED 1.67% no in-house ratios for this holding
MBX BIOSCIENCES INC UNSCREENED 1.24% no in-house ratios for this holding
ATAI ATAIBECKLEY INC NON_COMPLIANT 1.23% AAOIFI0.9% Usmani9.4% Dow Jones Islamic2.0% S&P Shariah2.5% MSCI Islamic9.4% MSCI Islamic M-Series2.5% FTSE Shariah8.7%
MONOPAR THERAPEUTICS INC UNSCREENED 1.21% no in-house ratios for this holding
DEFINIUM THERAPEUTICS INC UNSCREENED 1.18% no in-house ratios for this holding
XENCOR INC UNSCREENED 1.10% no in-house ratios for this holding
ZBIO ZENAS BIOPHARMA INC NON_COMPLIANT 1.06% AAOIFI3.9% Usmani11.3% Dow Jones Islamic8.0% S&P Shariah— MSCI Islamic11.3% MSCI Islamic M-Series— FTSE Shariah11.2%
UNIQURE NV UNSCREENED 1.06% no in-house ratios for this holding
APOGEE THERAPEUTICS INC UNSCREENED 1.02% no in-house ratios for this holding
VOR VOR BIOPHARMA INC NON_COMPLIANT 0.99% AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic0.6% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
RGNX REGENXBIO INC NON_COMPLIANT 0.97% AAOIFI13.9% Usmani14.3% Dow Jones Islamic13.6% S&P Shariah11.9% MSCI Islamic14.3% MSCI Islamic M-Series11.9% FTSE Shariah0.0%
LBRX LB PHARMACEUTICALS INC NON_COMPLIANT 0.94% AAOIFI0.4% Usmani1.1% Dow Jones Islamic— S&P Shariah— MSCI Islamic1.1% MSCI Islamic M-Series— FTSE Shariah0.0%
DMRA DAMORA THERAPEUTICS INC NON_COMPLIANT 0.93% AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.2% MSCI Islamic M-Series0.3% FTSE Shariah0.0%
AMYLYX PHARMACEUTICALS INC UNSCREENED 0.93% no in-house ratios for this holding
DYN DYNE THERAPEUTICS INC NON_COMPLIANT 0.93% AAOIFI7.0% Usmani17.7% Dow Jones Islamic9.1% S&P Shariah9.1% MSCI Islamic17.7% MSCI Islamic M-Series9.1% FTSE Shariah16.2%
ORUKA THERAPEUTICS INC UNSCREENED 0.93% no in-house ratios for this holding
NRIX NURIX THERAPEUTICS INC NON_COMPLIANT 0.92% AAOIFI4.2% Usmani5.5% Dow Jones Islamic4.4% S&P Shariah5.0% MSCI Islamic5.5% MSCI Islamic M-Series5.0% FTSE Shariah0.0%
ORIC ORIC PHARMACEUTICALS INC COMPLIANT 0.90% AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0%
GH RESEARCH PLC UNSCREENED 0.89% no in-house ratios for this holding
SION SIONNA THERAPEUTICS INC NON_COMPLIANT 0.88% AAOIFI5.6% Usmani2.9% Dow Jones Islamic0.7% S&P Shariah— MSCI Islamic2.9% MSCI Islamic M-Series— FTSE Shariah0.0%
DIANTHUS THERAPEUTICS INC UNSCREENED 0.87% no in-house ratios for this holding
ERASCA INC UNSCREENED 0.87% no in-house ratios for this holding
JBIO JADE BIOSCIENCES INC NON_COMPLIANT 0.86% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
SELLAS LIFE SCIENCES GROUP INC UNSCREENED 0.86% no in-house ratios for this holding
PALVELLA THERAPEUTICS INC UNSCREENED 0.86% no in-house ratios for this holding
RELAY THERAPEUTICS INC UNSCREENED 0.85% no in-house ratios for this holding
REPLIMUNE GROUP INC UNSCREENED 0.84% no in-house ratios for this holding
ALTO NEUROSCIENCE INC UNSCREENED 0.84% no in-house ratios for this holding
ADLAI NORTYE LTD UNSCREENED 0.84% no in-house ratios for this holding
BCAX BICARA THERAPEUTICS INC NON_COMPLIANT 0.84% AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.2% MSCI Islamic M-Series— FTSE Shariah0.0%
IMNM IMMUNOME INC NON_COMPLIANT 0.83% AAOIFI0.5% Usmani2.3% Dow Jones Islamic0.7% S&P Shariah0.9% MSCI Islamic2.3% MSCI Islamic M-Series0.9% FTSE Shariah0.0%
AVTX AVALO THERAPEUTICS INC NON_COMPLIANT 0.83% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.1% MSCI Islamic0.0% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
MGTX MEIRAGTX HOLDINGS PLC COMPLIANT 0.82% AAOIFI1.4% Usmani2.9% Dow Jones Islamic1.6% S&P Shariah2.0% MSCI Islamic2.9% MSCI Islamic M-Series2.0% FTSE Shariah0.0%
IDYA IDEAYA BIOSCIENCES INC NON_COMPLIANT 0.82% AAOIFI1.0% Usmani2.4% Dow Jones Islamic1.2% S&P Shariah1.1% MSCI Islamic2.4% MSCI Islamic M-Series1.1% FTSE Shariah0.0%
SPYGLASS PHARMA INC UNSCREENED 0.82% no in-house ratios for this holding
KODIAK SCIENCES INC UNSCREENED 0.82% no in-house ratios for this holding
RVMDW REVOLUTION MEDICINES INC NON_COMPLIANT 0.82% AAOIFI49.8% Usmani14.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic14.9% MSCI Islamic M-Series— FTSE Shariah11.3%
CELLDEX THERAPEUTICS INC UNSCREENED 0.82% no in-house ratios for this holding
SPYRE THERAPEUTICS INC UNSCREENED 0.82% no in-house ratios for this holding
CGEM CULLINAN THERAPEUTICS INC NON_COMPLIANT 0.81% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
LXRX LEXICON PHARMACEUTICALS INC NON_COMPLIANT 0.81% AAOIFI7.5% Usmani24.6% Dow Jones Islamic11.1% S&P Shariah11.4% MSCI Islamic24.6% MSCI Islamic M-Series11.4% FTSE Shariah21.4%
XENON PHARMACEUTICALS INC UNSCREENED 0.81% no in-house ratios for this holding
KYMR KYMERA THERAPEUTICS INC NON_COMPLIANT 0.80% AAOIFI0.7% Usmani4.3% Dow Jones Islamic1.4% S&P Shariah1.8% MSCI Islamic4.2% MSCI Islamic M-Series1.8% FTSE Shariah0.0%
BIOHAVEN LTD UNSCREENED 0.80% no in-house ratios for this holding
CG ONCOLOGY INC UNSCREENED 0.80% no in-house ratios for this holding
NKTR NEKTAR THERAPEUTICS NON_COMPLIANT 0.80% AAOIFI6.0% Usmani7.1% Dow Jones Islamic6.7% S&P Shariah9.2% MSCI Islamic7.1% MSCI Islamic M-Series9.2% FTSE Shariah0.0%
ENLIVEN THERAPEUTICS INC UNSCREENED 0.80% no in-house ratios for this holding
RCUS ARCUS BIOSCIENCES INC COMPLIANT 0.79% AAOIFI4.9% Usmani14.2% Dow Jones Islamic5.6% S&P Shariah6.2% MSCI Islamic14.2% MSCI Islamic M-Series6.2% FTSE Shariah12.5%
TYRA TYRA BIOSCIENCES INC COMPLIANT 0.79% AAOIFI0.4% Usmani0.8% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.8% MSCI Islamic M-Series0.5% FTSE Shariah0.0%
REZOLUTE INC UNSCREENED 0.79% no in-house ratios for this holding
COGENT BIOSCIENCES INC UNSCREENED 0.79% no in-house ratios for this holding
ALUMIS INC UNSCREENED 0.78% no in-house ratios for this holding
CADL CANDEL THERAPEUTICS INC NON_COMPLIANT 0.78% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
SANA BIOTECHNOLOGY INC UNSCREENED 0.78% no in-house ratios for this holding
ACHIEVE LIFE SCIENCES INC UNSCREENED 0.78% no in-house ratios for this holding
OLMA OLEMA PHARMACEUTICALS INC NON_COMPLIANT 0.78% AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
VIRIDIAN THERAPEUTICS INC UNSCREENED 0.78% no in-house ratios for this holding
PRAXIS PRECISION MEDICINES INC UNSCREENED 0.77% no in-house ratios for this holding
FDMT 4D MOLECULAR THERAPEUTICS INC NON_COMPLIANT 0.77% AAOIFI6.2% Usmani9.0% Dow Jones Islamic9.4% S&P Shariah6.5% MSCI Islamic9.0% MSCI Islamic M-Series6.5% FTSE Shariah4.6%
IMMUNOVANT INC UNSCREENED 0.77% no in-house ratios for this holding
BELITE BIO INC UNSCREENED 0.77% no in-house ratios for this holding
VAXCYTE INC UNSCREENED 0.76% no in-house ratios for this holding
DISC MEDICINE INC UNSCREENED 0.76% no in-house ratios for this holding
RCKT ROCKET PHARMACEUTICALS INC NON_COMPLIANT 0.76% AAOIFI14.3% Usmani13.1% Dow Jones Islamic6.6% S&P Shariah3.2% MSCI Islamic8.1% MSCI Islamic M-Series3.2% FTSE Shariah7.3%
GENERATE BIOMEDICINES INC UNSCREENED 0.76% no in-house ratios for this holding
NGNE NEUROGENE INC NON_COMPLIANT 0.76% AAOIFI1.6% Usmani2.0% Dow Jones Islamic2.0% S&P Shariah2.0% MSCI Islamic2.0% MSCI Islamic M-Series2.0% FTSE Shariah0.0%
SLDB SOLID BIOSCIENCES INC NON_COMPLIANT 0.76% AAOIFI2.8% Usmani5.0% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic5.0% MSCI Islamic M-Series4.6% FTSE Shariah0.0%
MAZE MAZE THERAPEUTICS INC COMPLIANT 0.75% AAOIFI3.3% Usmani11.7% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic11.7% MSCI Islamic M-Seriesfail FTSE Shariah7.6%
GPCR STRUCTURE THERAPEUTICS INC NON_COMPLIANT 0.75% AAOIFI0.5% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
JANX JANUX THERAPEUTICS INC NON_COMPLIANT 0.75% AAOIFI3.1% Usmani2.1% Dow Jones Islamic1.5% S&P Shariah1.3% MSCI Islamic2.1% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
CRVS CORVUS PHARMACEUTICALS INC COMPLIANT 0.74% AAOIFI0.1% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
DSGN DESIGN THERAPEUTICS INC NON_COMPLIANT 0.74% AAOIFI0.4% Usmani1.2% Dow Jones Islamic0.5% S&P Shariah0.6% MSCI Islamic1.2% MSCI Islamic M-Series0.6% FTSE Shariah0.0%
VIKING THERAPEUTICS INC UNSCREENED 0.74% no in-house ratios for this holding
EDGEWISE THERAPEUTICS INC UNSCREENED 0.74% no in-house ratios for this holding
AURA BIOSCIENCES INC UNSCREENED 0.73% no in-house ratios for this holding
ASMB ASSEMBLY BIOSCIENCES INC NON_COMPLIANT 0.73% AAOIFI0.5% Usmani0.7% Dow Jones Islamic0.7% S&P Shariah1.0% MSCI Islamic0.7% MSCI Islamic M-Series1.0% FTSE Shariah0.0%
VERADERMICS INC UNSCREENED 0.73% no in-house ratios for this holding
ABCL ABCELLERA BIOLOGICS INC NON_COMPLIANT 0.73% AAOIFI3.7% Usmani8.9% Dow Jones Islamic8.8% S&P Shariah9.6% MSCI Islamic8.9% MSCI Islamic M-Series9.6% FTSE Shariah0.0%
ALT ALTIMMUNE INC NON_COMPLIANT 0.73% AAOIFI11.3% Usmani7.3% Dow Jones Islamic7.7% S&P Shariah7.6% MSCI Islamic7.3% MSCI Islamic M-Series7.6% FTSE Shariah7.1%
ANNX ANNEXON INC COMPLIANT 0.72% AAOIFI9.8% Usmani29.2% Dow Jones Islamic46.7% S&P Shariah42.5% MSCI Islamic29.2% MSCI Islamic M-Series42.5% FTSE Shariah19.7%
MINERALYS THERAPEUTICS INC UNSCREENED 0.72% no in-house ratios for this holding
SCHOLAR ROCK HOLDING CORP UNSCREENED 0.72% no in-house ratios for this holding
RAPPORT THERAPEUTICS INC UNSCREENED 0.71% no in-house ratios for this holding
PHARVARIS NV UNSCREENED 0.71% no in-house ratios for this holding
ARVN ARVINAS INC NON_COMPLIANT 0.71% AAOIFI1.7% Usmani1.3% Dow Jones Islamic1.0% S&P Shariah0.6% MSCI Islamic1.3% MSCI Islamic M-Series0.6% FTSE Shariah0.1%
PRME PRIME MEDICINE INC NON_COMPLIANT 0.70% AAOIFI15.8% Usmani51.6% Dow Jones Islamic20.7% S&P Shariah19.0% MSCI Islamic51.6% MSCI Islamic M-Series19.0% FTSE Shariah0.0%
BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS INC NON_COMPLIANT 0.70% AAOIFI1.5% Usmani0.7% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0%
CLYM CLIMB BIO INC NON_COMPLIANT 0.70% AAOIFI0.2% Usmani0.5% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic0.5% MSCI Islamic M-Series0.4% FTSE Shariah0.0%
SVRA SAVARA INC NON_COMPLIANT 0.70% AAOIFI3.0% Usmani19.4% Dow Jones Islamic3.7% S&P Shariah4.0% MSCI Islamic19.4% MSCI Islamic M-Series4.0% FTSE Shariah19.4%
UPB UPSTREAM BIO INC NON_COMPLIANT 0.69% AAOIFI0.4% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.3% MSCI Islamic M-Series— FTSE Shariah0.0%
CTMX CYTOMX THERAPEUTICS INC NON_COMPLIANT 0.69% AAOIFI1.0% Usmani1.2% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic1.2% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
TSHA TAYSHA GENE THERAPIES INC NON_COMPLIANT 0.69% AAOIFI3.9% Usmani12.5% Dow Jones Islamic5.1% S&P Shariah6.4% MSCI Islamic12.5% MSCI Islamic M-Series6.4% FTSE Shariah10.9%
OCSAW OCULIS HOLDING AG NON_COMPLIANT 0.68% AAOIFI0.0% Usmani0.0% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.0% MSCI Islamic M-Series— FTSE Shariah0.0%
ABUS ARBUTUS BIOPHARMA CORP NON_COMPLIANT 0.68% AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
AKTIS ONCOLOGY INC UNSCREENED 0.67% no in-house ratios for this holding
VIR VIR BIOTECHNOLOGY INC NON_COMPLIANT 0.67% AAOIFI6.1% Usmani7.7% Dow Jones Islamic8.6% S&P Shariah8.1% MSCI Islamic7.7% MSCI Islamic M-Series8.1% FTSE Shariah0.0%
ALLO ALLOGENE THERAPEUTICS INC NON_COMPLIANT 0.66% AAOIFI26.5% Usmani15.0% Dow Jones Islamic17.8% S&P Shariah16.2% MSCI Islamic15.0% MSCI Islamic M-Series16.2% FTSE Shariah0.0%
MLTX MOONLAKE IMMUNOTHERAPEUTICS NON_COMPLIANT 0.66% AAOIFI10.6% Usmani18.8% Dow Jones Islamic4.7% S&P Shariah3.9% MSCI Islamic18.8% MSCI Islamic M-Series3.9% FTSE Shariah18.5%
IMMX IMMIX BIOPHARMA INC NON_COMPLIANT 0.66% AAOIFI0.2% Usmani0.3% Dow Jones Islamic0.4% S&P Shariah0.5% MSCI Islamic0.3% MSCI Islamic M-Series0.5% FTSE Shariah0.0%
PRTA PROTHENA CORP PLC NON_COMPLIANT 0.66% AAOIFI1.5% Usmani2.2% Dow Jones Islamic1.2% S&P Shariah0.8% MSCI Islamic2.2% MSCI Islamic M-Series0.8% FTSE Shariah0.0%
AVBP ARRIVENT BIOPHARMA INC NON_COMPLIANT 0.65% AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
CELCUITY INC UNSCREENED 0.65% no in-house ratios for this holding
STOK STOKE THERAPEUTICS INC NON_COMPLIANT 0.65% AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0%
SEPN SEPTERNA INC NON_COMPLIANT 0.64% AAOIFI1.2% Usmani3.6% Dow Jones Islamic2.1% S&P Shariahfail MSCI Islamic3.6% MSCI Islamic M-Seriesfail FTSE Shariah0.0%
50BA.SG BICYCLE THERAPEUTICS PLC NON_COMPLIANT 0.64% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
RXRX RECURSION PHARMACEUTICALS INC NON_COMPLIANT 0.64% AAOIFI4.4% Usmani6.1% Dow Jones Islamic7.3% S&P Shariah6.4% MSCI Islamic6.1% MSCI Islamic M-Series6.4% FTSE Shariah1.0%
ANAB ANAPTYSBIO INC NON_COMPLIANT 0.64% AAOIFI0.9% Usmani4.1% Dow Jones Islamic1.1% S&P Shariah1.3% MSCI Islamic4.1% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
LEXEO THERAPEUTICS INC UNSCREENED 0.63% no in-house ratios for this holding
CMPX COMPASS THERAPEUTICS INC NON_COMPLIANT 0.63% AAOIFI7.8% Usmani5.3% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic5.3% MSCI Islamic M-Series2.3% FTSE Shariah0.0%
EYPT EYEPOINT INC NON_COMPLIANT 0.63% AAOIFIfail Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
CMPS COMPASS PATHWAYS PLC NON_COMPLIANT 0.63% AAOIFI4.3% Usmani10.5% Dow Jones Islamic6.8% S&P Shariah7.7% MSCI Islamic10.5% MSCI Islamic M-Series7.7% FTSE Shariah9.8%
PROKIDNEY CORP UNSCREENED 0.63% no in-house ratios for this holding
WVE WAVE LIFE SCIENCES LTD NON_COMPLIANT 0.63% AAOIFI3.9% Usmani7.8% Dow Jones Islamic2.9% S&P Shariah3.6% MSCI Islamic7.8% MSCI Islamic M-Series3.6% FTSE Shariah0.0%
VERA THERAPEUTICS INC UNSCREENED 0.63% no in-house ratios for this holding
SUMMIT THERAPEUTICS INC UNSCREENED 0.62% no in-house ratios for this holding
TECX TECTONIC THERAPEUTIC INC NON_COMPLIANT 0.62% AAOIFI0.7% Usmani1.9% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic1.8% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
IMTX IMMATICS NV NON_COMPLIANT 0.62% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
NEWAMSTERDAM PHARMA COMPANY NV UNSCREENED 0.61% no in-house ratios for this holding
GLUE MONTE ROSA THERAPEUTICS INC NON_COMPLIANT 0.61% AAOIFI4.6% Usmani5.2% Dow Jones Islamic4.2% S&P Shariah5.4% MSCI Islamic5.2% MSCI Islamic M-Series5.4% FTSE Shariah0.0%
CABA CABALETTA BIO INC NON_COMPLIANT 0.60% AAOIFI2.0% Usmani6.9% Dow Jones Islamic1.9% S&P Shariah1.3% MSCI Islamic1.4% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
INHIBRX BIOSCIENCES INC UNSCREENED 0.60% no in-house ratios for this holding
NTLA INTELLIA THERAPEUTICS INC NON_COMPLIANT 0.59% AAOIFI16.8% Usmani25.5% Dow Jones Islamic16.2% S&P Shariah13.3% MSCI Islamic25.5% MSCI Islamic M-Series13.3% FTSE Shariah8.2%
BEAM BEAM THERAPEUTICS INC NON_COMPLIANT 0.59% AAOIFI10.7% Usmani19.2% Dow Jones Islamic9.9% S&P Shariah10.3% MSCI Islamic19.2% MSCI Islamic M-Series10.3% FTSE Shariah7.9%
TNGX TANGO THERAPEUTICS INC NON_COMPLIANT 0.59% AAOIFI0.7% Usmani3.0% Dow Jones Islamic1.8% S&P Shariah2.1% MSCI Islamic3.0% MSCI Islamic M-Series2.1% FTSE Shariah0.0%
CBIO CRESCENT BIOPHARMA INC NON_COMPLIANT 0.54% AAOIFI0.5% Usmani0.8% Dow Jones Islamic1.0% S&P Shariah1.3% MSCI Islamic0.8% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
RLMD RELMADA THERAPEUTICS INC NON_COMPLIANT 0.53% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
INVIVYD INC UNSCREENED 0.47% no in-house ratios for this holding
EVMN EVOMMUNE INC NON_COMPLIANT 0.38% AAOIFI2.5% Usmani2.9% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic2.7% MSCI Islamic M-Seriesfail FTSE Shariah0.0%
BIOA BIOAGE LABS INC NON_COMPLIANT 0.34% AAOIFI1.1% Usmani0.7% Dow Jones Islamic0.7% S&P Shariah— MSCI Islamic0.7% MSCI Islamic M-Series— FTSE Shariah0.0%
MPLT MAPLIGHT THERAPEUTICS INC NON_COMPLIANT 0.31% AAOIFI0.3% Usmani0.5% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.5% MSCI Islamic M-Series— FTSE Shariah0.0%
CAPR CAPRICOR THERAPEUTICS INC NON_COMPLIANT 0.10% AAOIFI19.1% Usmani27.9% Dow Jones Islamic11.8% S&P Shariah15.6% MSCI Islamic27.9% MSCI Islamic M-Series15.6% FTSE Shariah0.0%

The published standards disagree about this fund by 4 points of portfolio weight — 4.4% of it passes AAOIFI, 0.0% passes MSCI Islamic. Which number is yours depends on which standard you follow.

These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.

ratios pass on 4.4% ratios fail on 47.0% 51.8% not rated under AAOIFI

76 of 132 listed holdings carry our own per-methodology verdicts (55% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 71 (51% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.

Non-compliant holdingWeight
ATAI ATAIBECKLEY INC 1.23%
ZBIO ZENAS BIOPHARMA INC 1.06%
VOR VOR BIOPHARMA INC 0.99%
RGNX REGENXBIO INC 0.97%
LBRX LB PHARMACEUTICALS INC 0.94%
DMRA DAMORA THERAPEUTICS INC 0.93%
DYN DYNE THERAPEUTICS INC 0.93%
NRIX NURIX THERAPEUTICS INC 0.92%
SION SIONNA THERAPEUTICS INC 0.88%
JBIO JADE BIOSCIENCES INC 0.86%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure1 of 4 timeframes bullish · 94.1% aligned
VWAPPrice below VWAP ($41.50)
VolumeRelative volume 2.9× the 20-day average
Momentum10-day rate of change -8.8%

Virtus Biotech Clinical Trials Etf (BBC) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.

Market & analysts
Momentum (10d)
-8.8%
rate of change
SMC grade
C · 64
94.1% aligned
C · 64
SMC grade — 94.1% timeframe alignment
-8.8%
Rate of change (10d)

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for BBC — this runs off the critical path so the page paints first. It will appear here on its own.

Tracked investors holding BBC
InvestorFirmPositionWeightAs of
Ken Griffin Citadel Advisors $2M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

56.0350.2944.5638.8333.102025-11-192026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
37.56
S2
38.73
S1
39.45
PIVOT
40.62
R1
41.34
R2
42.51
R3
43.23

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
44.88 – 52.20
±7.54% from 48.54, made 2026-09-16 · resolves 2026-09-23
STRONG SELL
from 19 indicators
77.1% of our last 20463 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 50.1% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)38.70NEUTRAL
Stochastic %K (14)0.17BUY
CCI (20)-147.42BUY
Williams %R (14)-99.83BUY
MACD (12,26,9)-0.21SELL
ROC (10)-8.83SELL
Momentum (10)-3.85SELL
EMA (10)41.93SELL
SMA (10)42.53SELL
EMA (20)42.51SELL
SMA (20)42.58SELL
EMA (30)43.09SELL
SMA (30)42.30SELL
EMA (50)44.29SELL
SMA (50)44.16SELL
EMA (100)45.60SELL
SMA (100)48.23SELL
EMA (200)44.19SELL
SMA (200)45.69SELL

About Virtus Biotech Clinical Trials Etf

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 43
🕐 1H BEARISH 50
⏱ 15-Min BEARISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-8.8%
Rate of change (10d)
2.9×
Volume vs its 20-day average
-0.74
MACD (no fresh cross)
$40.07
Volume POC (today)
$39.95 – $40.27
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is a fund screened on its name?

No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.

What does unrated weight mean?

It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.

Does the issuer's board make it compliant?

It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.

How often is this re-screened?

When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.